{"id":"https://openalex.org/W4362525884","doi":"https://doi.org/10.1158/1535-7163.22497196","title":"Supplementary Figure 1 from Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer","display_name":"Supplementary Figure 1 from Antitumor Activity of the Hsp90 Inhibitor IPI-504 in HER2-Positive Trastuzumab-Resistant Breast Cancer","publication_year":2023,"publication_date":"2023-04-03","ids":{"openalex":"https://openalex.org/W4362525884","doi":"https://doi.org/10.1158/1535-7163.22497196"},"language":"en","primary_location":{"id":"doi:10.1158/1535-7163.22497196","doi":"https://doi.org/10.1158/1535-7163.22497196","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22497196","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1535-7163.22497196","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002819777","display_name":"Maurizio Scaltriti","orcid":"https://orcid.org/0000-0002-5522-1447","observed_orcids":["https://orcid.org/0000-0002-5522-1447"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Maurizio Scaltriti","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073423716","display_name":"Violeta Serra","orcid":"https://orcid.org/0000-0001-6620-1065","observed_orcids":["https://orcid.org/0000-0001-6620-1065"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Violeta Serra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048284232","display_name":"Emmanuel Normant","orcid":"https://orcid.org/0000-0002-0570-5072","observed_orcids":["https://orcid.org/0000-0002-0570-5072"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Emmanuel Normant","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085170830","display_name":"Marta Guzm\u00e1n","orcid":"https://orcid.org/0000-0002-0924-9887","observed_orcids":["https://orcid.org/0000-0002-0924-9887"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Marta Guzman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006524743","display_name":"Olga Catalina Rodriguez","orcid":"https://orcid.org/0000-0003-2017-1096","observed_orcids":["https://orcid.org/0000-0003-2017-1096"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Olga Rodriguez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028296814","display_name":"Alice R. Lim","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Alice R. Lim","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030056081","display_name":"Kelly L. Slocum","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kelly L. Slocum","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046123085","display_name":"Kip A. West","orcid":"https://orcid.org/0000-0002-3891-0830","observed_orcids":["https://orcid.org/0000-0002-3891-0830"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kip A. West","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018824605","display_name":"Varenka Rodriguez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Varenka Rodriguez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018105485","display_name":"Ludmila Prudkin","orcid":"https://orcid.org/0000-0001-5747-0706","observed_orcids":["https://orcid.org/0000-0001-5747-0706"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Ludmila Prudkin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020391246","display_name":"Jos\u00e9 Jimenez","orcid":"https://orcid.org/0000-0002-2576-1776","observed_orcids":["https://orcid.org/0000-0002-2576-1776"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Jimenez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112498455","display_name":"Claudia Monica Aura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Claudia Aura","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5004300577","display_name":"Jose M Baselga","orcid":"https://orcid.org/0000-0003-1361-4063","observed_orcids":["https://orcid.org/0000-0003-1361-4063"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jos\u00e9 Baselga","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5458999872207642,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.5458999872207642,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10934","display_name":"Heat shock proteins research","score":0.44510000944137573,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ipi-504","display_name":"IPI-504","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hsp90-inhibitors","display_name":"Hsp90 inhibitors","score":0.9509999752044678},{"id":"https://openalex.org/keywords/her2-positive-breast-cancer","display_name":"HER2-positive breast cancer","score":0.9649999737739563},{"id":"https://openalex.org/keywords/trastuzumab-resistance","display_name":"trastuzumab resistance","score":0.996999979019165},{"id":"https://openalex.org/keywords/anticancer-activity","display_name":"anticancer activity","score":0.9729999899864197}],"concepts":[{"id":"https://openalex.org/C2779786085","wikidata":"https://www.wikidata.org/wiki/Q412616","display_name":"Trastuzumab","level":4,"score":0.9577131271362305},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5996074080467224},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.5556749105453491},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5398115515708923},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5217146277427673},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.4638156294822693}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1158/1535-7163.22497196","doi":"https://doi.org/10.1158/1535-7163.22497196","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22497196","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},{"id":"pmh:oai:figshare.com:article/22497193","doi":null,"is_oa":true,"landing_page_url":"https://figshare.com/articles/journal_contribution/Supplementary_Figure_2_from_Antitumor_Activity_of_the_Hsp90_Inhibitor_IPI-504_in_HER2-Positive_Trastuzumab-Resistant_Breast_Cancer/22497193","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1158/1535-7163.22497196","doi":"https://doi.org/10.1158/1535-7163.22497196","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1535-7163.22497196","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4392681350","https://openalex.org/W2104508965","https://openalex.org/W2137105543","https://openalex.org/W2566530718","https://openalex.org/W7100101458","https://openalex.org/W3099781830","https://openalex.org/W6939650690","https://openalex.org/W6901910983","https://openalex.org/W2563050743","https://openalex.org/W4393865725"],"abstract_inverted_index":{"Supplementary":[0],"Figure":[1],"1":[2],"from":[3],"Antitumor":[4],"Activity":[5],"of":[6],"the":[7],"Hsp90":[8],"Inhibitor":[9],"IPI-504":[10],"in":[11],"HER2-Positive":[12],"Trastuzumab-Resistant":[13],"Breast":[14],"Cancer":[15]},"counts_by_year":[],"updated_date":"2026-10-17T09:40:24.721904","created_date":"2023-04-06T00:00:00"}